CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 4 Grant or award Chief Development Officer acquired 26,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K/A Event Exhibits
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 1,214,582 shares (grant or award)
- 4 Grant or award Director acquired 4,493,741 shares (grant or award)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 7,064 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Acquisition or sale completed · Executive or director change · Other events
- 8-K Event Shareholder vote results
Page 6 of 13 · 249 filings